Oaktree Acquisition Corp. III Life Sciences (OACC) Institutional Ownership $10.00 +0.01 (+0.10%) As of 02/21/2025 02:46 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)Number ofInstitutional Buyers(last 12 months)8Number ofInstitutional Sellers(last 12 months)0 Get OACC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oaktree Acquisition Corp. III Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OACC Institutional Buying and Selling by Quarter Oaktree Acquisition Corp. III Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 Toronto Dominion Bank1,436,900$14.36M0.0%N/A6.408% 2/17/2025 Two Sigma Investments LP437,500$4.36M0.0%N/A1.951% 2/17/2025 TENOR CAPITAL MANAGEMENT Co. L.P.300,000$2.99M0.0%N/A1.338% 2/17/2025 Toronto Dominion Bank1,436,900$14.36M0.0%N/A6.409% 2/17/2025 Sculptor Capital LP250,000$2.49M0.0%N/A1.115% 2/17/2025 Lighthouse Investment Partners LLC300,000$3.04M0.1%N/A1.338% 2/17/2025 K2 Principal Fund L.P.195,292$1.95M0.2%N/A0.871% 2/14/2025 AQR Arbitrage LLC1,980,285$19.74M0.4%N/A8.831% 2/14/2025 Shaolin Capital Management LLC550,000$5.48M0.1%N/A2.453% (Data available from 1/1/2016 forward) OACC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OACC shares? During the previous two years, the following institutional investors and hedge funds held shares of Oaktree Acquisition Corp. III Life Sciences shares: AQR Arbitrage LLC ($19.74M), Toronto Dominion Bank ($14.36M), Shaolin Capital Management LLC ($5.48M), Two Sigma Investments LP ($4.36M), Lighthouse Investment Partners LLC ($3.04M), TENOR CAPITAL MANAGEMENT Co. L.P. ($2.99M), and Sculptor Capital LP ($2.49M).Learn more on OACC's institutional investors. Which institutional investors have been buying Oaktree Acquisition Corp. III Life Sciences stock? The following institutional investors have purchased Oaktree Acquisition Corp. III Life Sciences stock in the last 24 months: Toronto Dominion Bank ($2.87M), AQR Arbitrage LLC ($1.98M), Shaolin Capital Management LLC ($550K), Two Sigma Investments LP ($437.50K), TENOR CAPITAL MANAGEMENT Co. L.P. ($300K), Lighthouse Investment Partners LLC ($300K), and Sculptor Capital LP ($250K). How much institutional buying is happening at Oaktree Acquisition Corp. III Life Sciences? Institutional investors have bought a total of 6,886,877 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies Orchid Island Capital Institutional Ownership Associated Capital Group Institutional Ownership Noah Institutional Ownership BrightSpire Capital Institutional Ownership KKR Real Estate Finance Trust Institutional Ownership SITE Centers Institutional Ownership Abacus Life Institutional Ownership Plymouth Industrial REIT Institutional Ownership Patria Investments Institutional Ownership Ares Acquisition Co. II Institutional Ownership This page (NASDAQ:OACC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
